Table 2.
Comparison of subgroups of women without gestational diabetes
| Non-gestational diabetes |
|||
|---|---|---|---|
| Parameters | Group 1 (n = 191) | Group 1 (n = 20) | Group 1 (n = 16) |
| Age (years) | 30.0 ± 0.4 | 31.0 ± 0.9 | 33.0 ± 0.4 |
| BMI (kg/m2) | 24.1 ± 0.2 | 24.4 ± 0.8 | 24.0 ± 0.2 |
| HbA1c (%) | 5.20 ± 0.03 | 5.25 ± 0.04 | 5.10 ± 0.02 |
| 1HGCT (mg/dL) | 105.9 ± 1.2 | 149.7 ± 2.3** | 150.3 ± 4.1** |
| Insulin (μU/mL) | 50.4 ± 2.9 | 73.7 ± 9.8 | 81.7 ± 15.7 |
| T-APN (μg/mL) | 8.68 ± 0.46 | 6.1 ± 0.5** | 5.45 ± 0.40** |
| HMW-APN (μg/mL) | 3.0 ± 0.1 | 2.8 ± 0.3 | 2.3 ± 0.3 |
| CRP (μg/mL) | 3.8 ± 0.3 | 6.0 ± 2.6 | 4.7 ± 0.9 |
| TNF-α (pg/mL) | 10.9 ± 0.3 | 11 ± 1 | 11 ± 1 |
| IL-6 (pg/mL) | 2.6 ± 0.2 | 2.4 ± 0.3 | 3.0 ± 0.6 |
| MCP-1 (pg/mL) | 62 ± 2 | 54.2 ± 3.7 | 76.2 ± 9.2 |
**
Data are the mean ± SEM. **P ≤ 0.001 compared with Group 1 women.
Group 1, women with glucose levels of <135 mg/dL 1 h after a 50-g glucose challenge test (1HGCT); Group 2, women with 1HGCT glucose ≥135 mg/dL and no abnormal readings on the 3-h oral glucose tolerance test (3HOGTT); Group 3, women with 1HGCT glucose ≥135 mg/dL and one abnormal reading on the 3HOGTT.
BMI, body mass index; T-APN, total adiponectin; HMW-APN, high molecular weight adiponectin; CRP, C-reactive protein; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1.